Inventor · disambiguated record
Raymond J. Patch
Also filed as: PATCH RAYMOND · PATCH RAYMOND J · PATCH RAYMOND JOSEPH
31 granted patents·9 pending applications·334 citations·filing 1991–2024
97Inventor score
Files withJANSSEN PHARMACEUTICA NV21JANSSEN BIOTECH INC6PROCEPT INC5BIGNAN GILLES1DANA FARBER CANCER INST INC1
Top patents by PatentIndex Score
40 records- 0197US11767354B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Sep 26, 2023·3 cites·23 claims
- 0296US10428134B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Oct 1, 2019·7 cites·21 claims
- 0395US11591379B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Feb 28, 2023·3 cites·20 claims
- 0494US11845808B2Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseasesJANSSEN BIOTECH INC·Filed 2021·Granted Dec 19, 2023·3 cites·30 claims
- 0594US10968265B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 6, 2021·4 cites·24 claims
- 0694US10787495B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Sep 29, 2020·3 cites·20 claims
- 0794US10640544B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted May 5, 2020·4 cites·28 claims
- 0894US7608622B2Imidazo[4,5-b]pyrazinone inhibitors of protein kinasesJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Oct 27, 2009·53 cites·6 claims
- 0993US11401315B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Aug 2, 2022·2 cites·24 claims
- 1093US10858413B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Dec 8, 2020·3 cites·17 claims
- 1193US7790724B2c-fms kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Sep 7, 2010·26 cites·9 claims
- 1293US5189046AProtein kinase C modulatorsNOVA PHARM CORP·Filed 1991·Granted Feb 23, 1993·61 cites·11 claims
- 1392US2025026803A1Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 1491US10968264B2Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 6, 2021·2 cites·31 claims
- 1591US10961293B2Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Mar 30, 2021·2 cites·14 claims
- 1689US2024018208A1Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide y receptorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 1786US2023365644A1Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide y receptorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 1885US7429603B2C-fms kinase inhibitorsDIMENSIONAL PHARM INC·Filed 2004·Granted Sep 30, 2008·29 cites·2 claims
- 1982US12018057B2Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseasesJANSSEN BIOTECH INC·Filed 2021·Granted Jun 25, 2024·1 cites·10 claims
- 2082US9193736B2PDE 10a inhibitors for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Nov 24, 2015·7 cites·14 claims
- 2182US7427683B2c-fms kinase inhibitorsORTHO MCNEIL PHARM INC·Filed 2004·Granted Sep 23, 2008·22 cites·4 claims
- 2279US11732019B2Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Aug 22, 2023·0 cites·15 claims
- 2378US12134636B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Nov 5, 2024·0 cites·35 claims
- 2476US7846953B2Substituted phenoxy thiazolidinediones as estrogen related receptor-α modulatorsJANSSEN PHARMACEUTICA NV·Filed 2008·Granted Dec 7, 2010·3 cites·17 claims
- 2574US7326788B2Quinolinone derivatives as inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Feb 5, 2008·8 cites·6 claims
- 2673US8796256B2Substituted thiazolidinedione indazoles, indoles and benzotriazoles as estrogen-related receptor-α modulatorsBIGNAN GILLES·Filed 2011·Granted Aug 5, 2014·3 cites·28 claims
- 2772US5677343ACompound for inhibiting HIV infectivityPROCEPT INC·Filed 1995·Granted Oct 14, 1997·25 cites·40 claims
- 2872US2024150405A1Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseasesJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 2972US2024383954A1Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseasesJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 3071US5614559ACompound for inhibiting HIV infectivityPROCEPT INC·Filed 1994·Granted Mar 25, 1997·19 cites·39 claims
- 3167US6075050ACompound for inhibiting HIV infectivityPROCEPT INC·Filed 1995·Granted Jun 13, 2000·19 cites·9 claims
- 3266US8344009B2Substituted phenoxy thiazolidinediones as estrogen related receptor-á modulatorsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Jan 1, 2013·1 cites·3 claims
- 3365US5596095AFormation and utility of sulfonic acid protecting groupsPROCEPT INC·Filed 1995·Granted Jan 21, 1997·9 cites·11 claims
- 3458US2024352073A1Bicyclic peptide inhibitors of interleukin-23 receptorJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 3557US2024409598A1Peptide inhibitors of interleukin-23 receptorJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 3646US6365625B1Compound for inhibiting HIV infectivityPROCEPT INC·Filed 1999·Granted Apr 2, 2002·5 cites·6 claims
- 3744US2005113566A1Inhibitors of C-FMS kinaseFiled 2004·Application pending·0 cites
- 3842US2006094081A1Crystal structure of the c-fms kinase domain: applications and use of heterologous substitutions of kinase insert domains for crystallizationSCHUBERT CARSTEN·Filed 2005·Application pending·0 cites
- 3937US5395827Aω-[2-(phosphonoalkyl)phenyl]-2-aminoalkanoic acids as antagonists of excitatory amino acid receptorsGUILFORD PHARM INC·Filed 1993·Granted Mar 7, 1995·7 cites·19 claims
- 4028US7247438B1Methods of identifying agents which enhance caspase activityDANA FARBER CANCER INST INC·Filed 1997·Granted Jul 24, 2007·0 cites·4 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →